<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8D55713A-87FD-4232-B50F-49BB01546C91"><gtr:id>8D55713A-87FD-4232-B50F-49BB01546C91</gtr:id><gtr:name>GE (General Electric Company)</gtr:name><gtr:address><gtr:line1>General Electric Company</gtr:line1><gtr:line2>3135 Easton Turnpike</gtr:line2><gtr:postCode>06828</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Neuroscience</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8D55713A-87FD-4232-B50F-49BB01546C91"><gtr:id>8D55713A-87FD-4232-B50F-49BB01546C91</gtr:id><gtr:name>GE (General Electric Company)</gtr:name><gtr:address><gtr:line1>General Electric Company</gtr:line1><gtr:line2>3135 Easton Turnpike</gtr:line2><gtr:postCode>06828</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A9864CC-840C-4343-8F71-04E5BBE66DEC"><gtr:id>6A9864CC-840C-4343-8F71-04E5BBE66DEC</gtr:id><gtr:firstName>Johannes</gtr:firstName><gtr:surname>Attems</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7274A110-2A1E-44F9-83FF-AB040EC20A2C"><gtr:id>7274A110-2A1E-44F9-83FF-AB040EC20A2C</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B75A4D00-70A2-47BB-9EA1-00DE8EAC9010"><gtr:id>B75A4D00-70A2-47BB-9EA1-00DE8EAC9010</gtr:id><gtr:firstName>Alan Jeffrey</gtr:firstName><gtr:surname>Thomas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F979E67B-B2CA-406C-A2B6-677149451FE6"><gtr:id>F979E67B-B2CA-406C-A2B6-677149451FE6</gtr:id><gtr:firstName>Raj</gtr:firstName><gtr:surname>Kalaria</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL016451%2F1"><gtr:id>8FF4BC3E-B3FF-4F3A-A5FC-11B881E7D0C5</gtr:id><gtr:title>MRC Brain Banks: Joint application to underpin neuroscience research</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L016451/1</gtr:grantReference><gtr:abstractText>This application plans to support research into the causes and potential treatment of a range of diseases affecting the brain, some of which have been identified as priorities for research, such as dementia. The UK has a network of established Brain Banks that provide human tissue samples to a wide range of researchers. Human tissue samples have allowed a better understanding of the mechanisms operating in these complex disorders and have already aided the development of treatments for Alzheimer's disease and Parkinson's disease. 

This application will support four Brain Banks in Edinburgh, London, Newcastle and Oxford. These banks each have areas of particular interest, Parkinson's disease, Alzheimer's disease and motor neurone disease. However, in addition to the collection of tissues samples from patients with brain disorders, it is also essential to collect normal tissue samples for use as controls in research. Two of the Banks have a major focus in this area, so this application will support the collection of both disease and normal tissue samples. 

The banks will support scientific research by providing human tissue samples in an efficient and cost effective manner, while ensuring the samples provided are of the high quality required by researchers. The banks have worked to improve their efficiency, reducing the time required to provide the samples to researchers. Details of the samples available in each of the banks are included in a database, which is accessible through the internet. This allows researchers to see what samples are available and how to request these samples for their research in an easy way that will save time and speed up progress. 

All four Brain Banks in this application have approval from an Ethics Committee to ensure that their working practices meet nationally agreed standards that apply to work with human tissue samples. The work of each Bank is overseen by a local steering committee that includes members of the public and ethics experts as well as scientists and pathologists. Brain Banking is expensive, but the operating costs of these four banks are far less than their equivalents in Europe and in the USA. 

The challenges of developing treatments for complex diseases such as Alzheimer's disease and Parkinson's disease are considerable, but the Brain Banks in this application will play an important role in underpinning the scientific research in these national priority areas.</gtr:abstractText><gtr:technicalSummary>This joint application from the MRC Brain Banks in Edinburgh, London, Newcastle and Oxford is submitted in accordance with the wishes of the MRC Neuroscience and Mental Health Board (NMHB). After the last funding round for the MRC Brain Banks in 2011, NMHB indicated that a future joint application would be preferred and that the applicants should demonstrate progress in efficiency and improving standards of work in accordance with an agreed set of metrics. This application fulfils this request, and aims to underpin neuroscience research in the UK by providing high-quality human brain tissue samples and data in the formats required by researchers in both academic and industrial settings. The four banks in this application together cover the collection of human tissue samples from a range of major neurological diseases, and normal tissue samples to act as controls. This provides an invaluable resource to underpin neuroscience research in UK, particularly in recently identified priority areas such as dementia. 

The banks hve demonstrated in this application that they can work to the standards set in the metrics agreed with the NMHB, and have improved their efficiency of operations. The banks already support a number of major researchers in academia and industry in UK and overseas, including several who are currently funded by MRC. The provision of high quality tissue samples and accompanying data is essential for the success of these projects; the MRC brain banks constitute a critical infrastructure for this research.

In order to develop this important work further, funding for a 5 year period is requested; earlier funding awards for periods of 2 years has not been conducive to long term planning and strategy. The costs of brain banking in the UK compare very favourably with those in Europe and in the USA; over the next 5 years the banks will continue to work to improve efficiency of operation and to operate a cost recovery programme in keeping with MRC policy.</gtr:technicalSummary><gtr:potentialImpactText>The activities of the brain banks will be of major significance to neuroscience researchers in the UK and the banks plan to capitalise upon this by promoting the availability of their tissue samples during the course of this grant, primarily by the MRC database, which will give details of all samples currently available, including control samples. This promotion will not be confined to academic researchers, but also through the Association of British Pharmaceutical Industries the applicants will promote the availability of the tissue samples in their banks and will engage with both academic and industrial researchers to help provide the samples they require.

The brain banks already supply tissue samples to commercial companies for their research and development purposes and it is planned to continue and develop these contacts within an appropriate framework. 

The applicants are involved in a number of local, national and international committees and bodies that relate to research. Policymakers within both government (DH) and non-governmental organisations and regulators (e.g. the Human Tissue Authority) will benefit from information arising from the use of human brain tissue samples and also from the general promotion of brain donation in neuroscience research.

The applicants have previously engaged with museums (including the Wellcome Trust museum) and charities including the Alzheimer's Society, Alzheimer's Research UK, the Multiple Sclerosis Society and Parkinson's UK to provide expert advice on brain banking. The applicants also work within the committee structure of these charities to advise on their research activities, particularly those that might involve the collection and use of human tissue samples.

The wider public is likely to benefit from this planned research, particularly if the tissue samples provided result in improved diagnosis or treatment for patients with neurodegenerative disorders. Furthermore, the promotion of brain banking and the value of brain donation for research will help raise public awareness of the challenges of dementia and neurodegenerative diseases, and help make individuals take an informed choice on this complex matter. 

It is likely that the government may benefit from this research, particularly in respect to the activities of the Ministerial Action Group on Dementia Research and the Prime Minister's Challenge on dementia, within which brain banking is acknowledged as an essential requirement to support researchers in this field. The support requested in this application will be of wider benefit to these government initiatives and the research arising from this work, supported by other government funded bodies including NIHR.

Finally, MRC is likely to benefit from this research, since the applicants already provide large numbers of tissue samples to researchers such as Professor John Hardy, UCL, who are in receipt of significant funding from MRC to undertake research projects that are critically dependent on a continuous supply of high quality tissue samples that will be collected and made available during the course of this proposal.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-11-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1198363</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GE Healthcare</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Global Research Centre, Biosciences</gtr:department><gtr:description>GE Healthcare Biomarkers</gtr:description><gtr:id>A6C6C60E-6C95-4BFD-B6FC-F87309A10E7D</gtr:id><gtr:impact>Patents granted. 
PCT/EP2009/055944 GABA Biomarkers For Depression
PCT/EP2009/055945 Glutamine Biomarkers For Depression
Manuscripts in preparation, further multidisciiplinary collaborative work in same area being planned involving molecular biology and electrophysiology. No major outcomes yet.</gtr:impact><gtr:outcomeId>Y1sJnF94m7e-1</gtr:outcomeId><gtr:partnerContribution>A listing of potential neuroimaging targets for the diagnosis of depression identified by proteomic and whole genome expression profiling of selected brain regions in individuals with treatment resistant late onset depression.</gtr:partnerContribution><gtr:piContribution>A listing of potential neuroimaging targets for the diagnosis of depression identified by proteomic and whole genome expression profiling of selected brain regions in individuals with treatment resistant late onset depression.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GE Healthcare</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Global Research Centre, Biosciences</gtr:department><gtr:description>GE Healthcare Biomarkers</gtr:description><gtr:id>F3543FDC-A6FE-47BE-A833-6D2F8D40E732</gtr:id><gtr:impact>Patents granted.
PCT/EP2009/055944 GABA Biomarkers for depression.
PCT/EP2009/055945 Gluatmine Biomarkers for depression.
Manuscripts in preparation No major outcomes yet.</gtr:impact><gtr:outcomeId>s87ytfe6CuU-1</gtr:outcomeId><gtr:partnerContribution>A listing of potential neuroimaging targets or the diagnosis of depression identified by whole genome expression profiling of selected brain regions in individuals with late onset depression.</gtr:partnerContribution><gtr:piContribution>A listing of potential neuroimaging targets or the diagnosis of depression identified by whole genome expression profiling of selected brain regions in individuals with late onset depression.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>The Newcastle Brain Tissue Resource - A Biobank for the Study of Human Neurological and Psychiatric Disorders</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1354C195-71E6-4DD9-8391-01F8438CC3D1</gtr:id><gtr:impact>Approximately 50 delegates of the SONA 2013 Conference, Morocco, attended the presentation given by Mrs Keers. Mrs Keers described the Newcatle Brain Tissue Resource (NBTR) and answered questions in the discussion e.g., how can researchers ask for brain tissue from the NBTR

Increased international awareness of the availability of well chracterised human brain tissue for research.</gtr:impact><gtr:outcomeId>QekP5GpWMRG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PSP Association</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>25833763-C57C-46D7-8D88-D4FD7E80E3DC</gtr:id><gtr:impact>Talk to the local PSP Association group about the work of the NBTR and about clinical trials and research.

Invited back to two further additional meetings and to give updates on research.</gtr:impact><gtr:outcomeId>fJuMZEsfdFW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Science Festival 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B065C512-863B-4E16-9FD8-0C9330C58E1F</gtr:id><gtr:impact>Two small workshops titled &amp;quot;How does my Brain Age?&amp;quot; and &amp;quot;Make your own Homunculus&amp;quot; as part of the British Science Festival 2013 aimed at all ages and informing them about how the brain works and what happens when it doesn't work. Over 200 participants came to the events as part of the festival.

None to date</gtr:impact><gtr:outcomeId>bwDQnmxg7Sn</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.britishscienceassociation.org/british-science-festival</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Meetings</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7FC3EBC1-43E7-44B1-8A5D-B62F7A96F1DB</gtr:id><gtr:impact>We have hosted a series of public events speaking to local patient groups, and older peoples groups explaining the value of autopsy research and this is inevitably of interest and well received

We have had a substantial increase in sign-up for normal volunteers for autopsy donation especially since the advent of the BDR scheme and the new MRC network</gtr:impact><gtr:outcomeId>jnUwzfVzJao</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Meetings</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7889B3D4-53CE-48A8-BAA1-163DB3D7EDDB</gtr:id><gtr:impact>We have hosted a series of public events speaking to local patient groups, and older peoples groups explaining the value of autopsy research and this is inevitably of interest and well received

We have had a substantial increase in sign-up for normal volunteers for autopsy donation especially since the advent of the BDR scheme and the new MRC network</gtr:impact><gtr:outcomeId>fxbGaVkNRoG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brains for Dementia Research Ethics Study Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>41E9E620-2950-4011-A5F1-86F934E648A9</gtr:id><gtr:impact>Approximately 40 people attended the workshop and matters regarding both ethic an dlegela implications of brain donation were discussed

Increased understanding of legal and ethic implications in Barin Banking</gtr:impact><gtr:outcomeId>BkqAgWujuUg</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hexham ADS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>47CD7C28-9FAB-4E61-BD7F-BA22396EE540</gtr:id><gtr:impact>20 Members of the Hexham branch of the Alzheimer's disease Society attended a talk on dementia research

Asked to give a talk at another branch to Society members</gtr:impact><gtr:outcomeId>jv2XXovG32P</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public meetings</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BBA39392-F71F-4C83-9CEF-EF8CE20DE4BB</gtr:id><gtr:impact>We have hosted a series of public events speaking to local patient , society and older peoples groups explaining the value of autopsy research and this is inevitably of interest and well received

We have had a substantial increase in sign-up for normal volunteers for autopsy donation especially since the advent of the BDR scheme and the new MRC network</gtr:impact><gtr:outcomeId>pHD8xoGNXdR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Televison and Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CE87AA16-7DFA-4E94-A291-1600141850AB</gtr:id><gtr:impact>We took part in interviews and question and answer sessions on local radio and on local TV to highlight the need for autopsy donation.

Several individuals contacted us directly following the publicity and expressed an interest in receiving further information about tissue donation.</gtr:impact><gtr:outcomeId>LjjiJtJ4uFW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV and Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>613FA0E1-92E4-4361-A7C2-2A1F0D3B2CD1</gtr:id><gtr:impact>We took part in interviews and question and answer sessions on local radio and on local TV to highlight the need for autopsy donation.

Several individuals contacted us directly following the publicity and expressed an interest in receiving further information about tissue donation.</gtr:impact><gtr:outcomeId>kWvuNriQHqq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV and Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2F2A699-C26A-4D9D-A4EC-115AB76983E3</gtr:id><gtr:impact>We took part in interviews and question and answer sessions on local radio and on local TV to highlight the need for autopsy donation.

Several individuals contacted us directly following the publicity and expressed an interest in receiving further information about tissue donation.</gtr:impact><gtr:outcomeId>REvSE3Qg4YJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>U3A Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CCE1D131-6208-4B4A-8A50-099D8F4B7773</gtr:id><gtr:impact>Approximately 50 members of the public attended a talk on the work of the NBTR. There was a lively and interested discussion afterwards about clinical trials and brain tissue donation for research.

Have been invited to give another talk next year and also several inquiries about volunteering have been made</gtr:impact><gtr:outcomeId>iy5bRBdjq41</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Televison and Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FA101934-6EA0-4AF3-88B2-06E921A5B231</gtr:id><gtr:impact>We took part in interviews and question and answer sessions on local radio and on local TV to highlight the need for autopsy donation.

Several individuals contacted us directly following the publicity and expressed an interest in receiving further information about tissue donation.</gtr:impact><gtr:outcomeId>jXgBB4TS5w3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public meetings</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C7B08A2E-960A-45CB-8954-67FB507695A0</gtr:id><gtr:impact>We have given 2-3 per year meetings with older peoples groups and healthcare charites eg Age Concern, Alzheimers Society ar which we inform them about our work, invite comment and try to engage people in our studies

Requests for more events and enrollment of normal elderly controls.</gtr:impact><gtr:outcomeId>rkZL36Pw6jq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dystonia Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9D36CF78-EAF9-470A-9E09-9E2C8858F56E</gtr:id><gtr:impact>Talk to members of the Society on 16th March in Gateshead to demonstrate activities in relation to brain donation and research

Additional declarations of intent</gtr:impact><gtr:outcomeId>pRyu7bXv6Aw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio Newcastle and ARUK</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C641D05E-9083-4E02-908D-6D7E0D1D15B7</gtr:id><gtr:impact>Speaker on BBC Radio Newcastle about ARUK/ BDR and the charity event by Matt Burke local PhD student

additional enquiries about brain donation</gtr:impact><gtr:outcomeId>b4gvpddMDtX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>U3A Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AEA8F0BF-772D-493B-B34B-F5E50CE7EA0E</gtr:id><gtr:impact>Approximately 50 members of the public attended a talk on the work of the NBTR. There was a lively and interested discussion afterwards about clinical trials and brain tissue donation for research.

Have been invited to give another talk next year and also several inquiries about volunteering have been made</gtr:impact><gtr:outcomeId>cHkS6U8W1oh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E5111E93-1A0E-4A53-8F6E-E812A8F7F5AE</gtr:id><gtr:impact>Approximately 100 memebers of the public attended the event and asked very important questions, e.g. how is success in ageing research defined?

J Attems explained the need for Brain Banking in dementia research and this lead to severeal members of teh public asking about further details as to how they could donate brains.</gtr:impact><gtr:outcomeId>SiQ5uPfs1N6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Science Festival Brain Awareness Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>05180BE3-B2B7-4384-B66A-10BFC6480EF4</gtr:id><gtr:impact>Dementia Research Audience of children aged 4-16, ~200 visitors undertaking interactive event

Variety of follow on enquiries about dementia research</gtr:impact><gtr:outcomeId>54539ca057adf6.49663064</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PSP Association</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5692E491-8750-4423-9831-7ED2834BE4CA</gtr:id><gtr:impact>Talk to the local PSP Association group about the work of the NBTR and about clinical trials and research.

Invited back to two further additional meetings and to give updates on research.</gtr:impact><gtr:outcomeId>jS9aYp8rnz1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Awarness Day by North Durham Parkinson's UK</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DE748EDF-8B8D-44FA-B607-1CF6F4DAF38C</gtr:id><gtr:impact>Presentation and Display Stand on 20th March at Durham Town Hall in support of Awareness Eevent for Parkinson's UK

Additional declarations of intent and involvement in clinical research</gtr:impact><gtr:outcomeId>bunwnEQThfm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sunderland Alzheimer's Society Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>53A20B53-294E-4989-AA54-85DE005F3622</gtr:id><gtr:impact>Talk on research progress and brain banking to local group on 29th April

None to date</gtr:impact><gtr:outcomeId>WLCtT5GkSus</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson UK North Durham Branch</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F25AC7AF-D19D-43DB-BB3D-E370A0C71545</gtr:id><gtr:impact>Gave talk to 30 members of the North Durham Branch of Parkinson UK on brain donation on 27th September

None so far</gtr:impact><gtr:outcomeId>PzQBUg8mivQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR Engagement Event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5D2D9579-85A3-448C-8A74-370D1821938E</gtr:id><gtr:impact>Talk and workshop with 150 members of the public to demonstrate work done and to stimulate discussion

Several members of the public contacted us to join clinical studies and to register for donation.</gtr:impact><gtr:outcomeId>ETuMRxPveA9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>553000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Intermediate Clinical Fellowship</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Newcastle University</gtr:fundingOrg><gtr:id>AE7B0EF6-4BB1-41CE-85CA-DADDE1AE1294</gtr:id><gtr:outcomeId>RxWU1JciWrJ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5286479</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Newcastle Biomedical Research Centre</gtr:department><gtr:description>Biomedical Research Centre in Ageing</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>EFFE8FB5-1701-4B9C-AFCD-CAAD1B818829</gtr:id><gtr:outcomeId>Kv3LMoMgrsk</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2030000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>HTA</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>3A2342B9-B656-4B96-8ABB-4B24A030B7F8</gtr:id><gtr:outcomeId>jVEpHri2oYc</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>480432</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BDR2 - Alzheimer's Brian Bank UK/Brains for Dementia Research</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Alzheimer?s Brain Bank UK (ABBUK)</gtr:fundingOrg><gtr:id>D7932B08-74D8-4C0D-92A3-EDB2BC47C540</gtr:id><gtr:outcomeId>Ty6Kbhjjjqe</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>206031</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Multimorbidity in the ageing human brain - assessment by quantitive neuropathology</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:id>4F31B79D-BF3B-4966-A971-4950E7B88404</gtr:id><gtr:outcomeId>e3cHSHaQM94</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>178419</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Molecular Mechanisms Underlying Visual Hallucinations in Dementia with Lewy Bodies</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>B6334DAE-61FA-46D8-82E2-EF1C9BFE004D</gtr:id><gtr:outcomeId>dqrmZEowsnm</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7175</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Assessment of neuropathological changes associated with vascular dementia: validation of a consensus approach</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>FB248073-9823-46D4-9AA4-4FAD92529368</gtr:id><gtr:outcomeId>Aas6VkGBApi</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Newcastle Biomedical Research Centre</gtr:department><gtr:description>Biomedical Research Unit On Lewy Body Diseases</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0BE886E5-0770-44BF-A37F-FC2C4891F426</gtr:id><gtr:outcomeId>hxhn872ekji</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Newcastle Biomedical Research Centre</gtr:department><gtr:description>Biomedical Research Centre in Ageing</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>98D7A860-8FD1-491C-8D68-44F1B5B2C1D4</gtr:id><gtr:outcomeId>CJNUFcsgxiu</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>68364</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BRU Project- Quantification of A-Synuclein Pathology in DLB and PDD</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>06E0489C-F0D7-4ECD-9131-720F48830328</gtr:id><gtr:outcomeId>gFEYiy7sYBp</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2C034973-E9C8-465D-8492-2B003D85EE46</gtr:id><gtr:title>Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d701cd80451e6067dc025280135c8c99"><gtr:id>d701cd80451e6067dc025280135c8c99</gtr:id><gtr:otherNames>Vallortigara J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>56bdf0bd738507.78446699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4088B4C-C050-4D59-855E-CC7B7A22CF30</gtr:id><gtr:title>Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/510b2b86704c6384a745cb85bc7dfa15"><gtr:id>510b2b86704c6384a745cb85bc7dfa15</gtr:id><gtr:otherNames>Zaccai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56bdf0c4360ee0.81569506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29C0894A-B9D6-4D83-BEE7-1DDEED843FE8</gtr:id><gtr:title>Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7.</gtr:title><gtr:parentPublicationTitle>Clinical neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0722-5091</gtr:issn><gtr:outcomeId>pm_14481_21_21176711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A94708C2-345F-4CA2-8882-916E4DDBFD5D</gtr:id><gtr:title>Causes of Death in Adults with Mitochondrial Disease.</gtr:title><gtr:parentPublicationTitle>JIMD reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c8753f936262d288af4ec7cc62d3755"><gtr:id>4c8753f936262d288af4ec7cc62d3755</gtr:id><gtr:otherNames>Barends M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2192-8304</gtr:issn><gtr:outcomeId>56bdf0be04b5f7.76956549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE3AEF66-0E0A-4489-B622-D7D6F17119D5</gtr:id><gtr:title>Stage-specific changes in neurogenic and glial markers in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2390a332c9de21dee0b9e94eaeeb4d7b"><gtr:id>2390a332c9de21dee0b9e94eaeeb4d7b</gtr:id><gtr:otherNames>Ekonomou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>56bdf0c6a18d79.24749179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A32A6479-97F2-4C4D-978A-9274E4529991</gtr:id><gtr:title>Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2db245c76b89ef2ac87eeb7602629d21"><gtr:id>2db245c76b89ef2ac87eeb7602629d21</gtr:id><gtr:otherNames>Chiasserini D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>56bdf0ba95f9f8.86768558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED108D19-72CD-4E71-880E-44C8F3D27284</gtr:id><gtr:title>Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1da287f55a621cd5e9876bc34531117"><gtr:id>e1da287f55a621cd5e9876bc34531117</gtr:id><gtr:otherNames>Howlett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56bdf0c675be06.57782234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43F007F8-DB7E-4337-82F7-490E7044346A</gtr:id><gtr:title>TDP-43 pathology in the population: prevalence and associations with dementia and age.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2322607362669cef0c609951a22d7d1a"><gtr:id>2322607362669cef0c609951a22d7d1a</gtr:id><gtr:otherNames>Keage HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>56bdf0c56bf6e2.87088585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>128F9A11-70FD-4B11-A3E0-3BABAF03989F</gtr:id><gtr:title>Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b9bdf6846b8ebf535c64350b137b2b"><gtr:id>c5b9bdf6846b8ebf535c64350b137b2b</gtr:id><gtr:otherNames>Kirby J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_55faa1aa17d1937b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16D6B473-988F-4373-9CFD-78512493B452</gtr:id><gtr:title>Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7df5df6eb873dcd36d2da09e2f2c5a58"><gtr:id>7df5df6eb873dcd36d2da09e2f2c5a58</gtr:id><gtr:otherNames>Baborie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5675dbb92a6e2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1284AC08-0123-43DB-AC43-318275891CDC</gtr:id><gtr:title>Variation in tau isoform expression in different brain regions and disease states.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>doi_14481_013_01_017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F2C896-A7D0-41C4-BCFE-08A495DFDE72</gtr:id><gtr:title>Neuropathologic Characterization of Pontocerebellar Hypoplasia Type 6 Associated With Cardiomyopathy and Hydrops Fetalis and Severe Multisystem Respiratory Chain Deficiency due to Novel RARS2 Mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>56bdf0c1c99cc7.90288080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>988B5750-7E1C-4A3D-8EC0-680AEA04FE40</gtr:id><gtr:title>White matter connections of the supplementary motor area in humans.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba9039867455ffc48b92db279df2d289"><gtr:id>ba9039867455ffc48b92db279df2d289</gtr:id><gtr:otherNames>Vergani F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>doi_55faa1aa17e34f51</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47CD94CA-CA1A-4647-A70C-DEF325AC9E6F</gtr:id><gtr:title>Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8560799503306007f4fa1d8d856f8ad8"><gtr:id>8560799503306007f4fa1d8d856f8ad8</gtr:id><gtr:otherNames>Thal DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>5675de467eb20</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72580011-6A25-47C6-8423-C305E9D6A084</gtr:id><gtr:title>Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c58c64d02a3edc3d0ae27f66455b7e2"><gtr:id>6c58c64d02a3edc3d0ae27f66455b7e2</gtr:id><gtr:otherNames>Garwood CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>56bdf0c3523433.77719645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0605FCD9-F1E3-4967-8044-731BD1C80559</gtr:id><gtr:title>Triplex real-time PCR--an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbb354db3fe15f02e9119f525c22a31a"><gtr:id>dbb354db3fe15f02e9119f525c22a31a</gtr:id><gtr:otherNames>Rygiel KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56bdf0bea30325.81120249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77321785-A8FC-4941-BAA0-F22CBB84C054</gtr:id><gtr:title>Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bb0f592e8014472d5082208157baad"><gtr:id>c5bb0f592e8014472d5082208157baad</gtr:id><gtr:otherNames>Cooper-Knock J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bdf0c599ec92.90874318</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC382BBE-BD16-459F-A7EA-26A752F41255</gtr:id><gtr:title>Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e591749d9e03d48c9eff836f040718"><gtr:id>11e591749d9e03d48c9eff836f040718</gtr:id><gtr:otherNames>Chen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56bdf0bf7d9868.62482683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC071698-BEA0-4808-910D-DB1331D24368</gtr:id><gtr:title>Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.</gtr:title><gtr:parentPublicationTitle>American journal of neurodegenerative disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce6eeacfdcd5222747dab3fa256a93b"><gtr:id>1ce6eeacfdcd5222747dab3fa256a93b</gtr:id><gtr:otherNames>Love S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2165-591X</gtr:issn><gtr:outcomeId>56bdf0bfa98a65.08423771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E3A771C-9C7B-4BE5-93A6-3A5CB6FE0D0E</gtr:id><gtr:title>Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56bdf0bf3604d7.39377807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A42D591E-C1FA-4624-97AA-22C632F5D7EB</gtr:id><gtr:title>Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/838fe8328565746cbb0656af8e5b7718"><gtr:id>838fe8328565746cbb0656af8e5b7718</gtr:id><gtr:otherNames>Steinacker P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>545b4061a2d548.14198584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23E0E795-B3F8-47C8-A1FC-5B39D5669ED6</gtr:id><gtr:title>Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373ede94ea3c44d7eca786be0b2c1d90"><gtr:id>373ede94ea3c44d7eca786be0b2c1d90</gtr:id><gtr:otherNames>Whitfield DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56bdf0c13db885.12170325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4877F032-CBF3-4F36-A948-4BC66A7F6A77</gtr:id><gtr:title>Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56bdf0c49268c8.87103698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87E89E12-FA36-4FBA-B3DE-3E25F99580F0</gtr:id><gtr:title>Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd5e73342d20ae8649c96a6a2691d6eb"><gtr:id>fd5e73342d20ae8649c96a6a2691d6eb</gtr:id><gtr:otherNames>Carbutt S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>56bdf0c27ef0e7.77824392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C2079C5-5C49-48E7-BB45-3296A5FB7C52</gtr:id><gtr:title>Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0733b0bf6944a47871438903c1344e91"><gtr:id>0733b0bf6944a47871438903c1344e91</gtr:id><gtr:otherNames>Burke MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481__nan_12085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A25059FE-B3A2-43D1-9E28-7F5FB60182DE</gtr:id><gtr:title>The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/743ca616d050cb2e43daf59d7a38b3c9"><gtr:id>743ca616d050cb2e43daf59d7a38b3c9</gtr:id><gtr:otherNames>Spilsbury A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>doi_55faa1aa18019848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFB14AB-D2E0-4E8C-923A-C415B8624197</gtr:id><gtr:title>Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49556e9fdf0c03f1e42f752a9d5ca04e"><gtr:id>49556e9fdf0c03f1e42f752a9d5ca04e</gtr:id><gtr:otherNames>Lax NZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0bf052920.11098279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F3F897F-65DD-4DFA-B468-BA79BBC3FBE0</gtr:id><gtr:title>A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_14481_21_23588557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21731715-3FAB-42A9-95ED-027B569E7D87</gtr:id><gtr:title>Aggregated a-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/698dce08335e33c54f81143559203d23"><gtr:id>698dce08335e33c54f81143559203d23</gtr:id><gtr:otherNames>Reeve AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56bdf0be5f9f89.70982728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BB5717A-250C-4FBB-97D3-4165104B3C4E</gtr:id><gtr:title>Exome sequencing in dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>56bdf0b9935430.16585895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08C244D8-7452-4CA0-994B-49ACD3790F06</gtr:id><gtr:title>Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56bdf0c2523cd0.29885673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05CCF8BF-CD24-40A1-8134-0714476FCA4E</gtr:id><gtr:title>Can oral infection be a risk factor for Alzheimer's disease?</gtr:title><gtr:parentPublicationTitle>Journal of oral microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70731984b3bea0a4123c28b2728cb71c"><gtr:id>70731984b3bea0a4123c28b2728cb71c</gtr:id><gtr:otherNames>Olsen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2000-2297</gtr:issn><gtr:outcomeId>56bdf0c6d81f70.15145719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BED4508-F01A-4512-B3A4-BCCFF3F7101A</gtr:id><gtr:title>Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b9daf5a88de10a2e644ad67b7da22b3"><gtr:id>3b9daf5a88de10a2e644ad67b7da22b3</gtr:id><gtr:otherNames>Carare RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481__nan_12042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>883849C4-9D63-4A2C-B769-01DDAEA955D1</gtr:id><gtr:title>Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord.</gtr:title><gtr:parentPublicationTitle>Brain structure &amp; function</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73c5a5443c854df1dd9fa7a035002577"><gtr:id>73c5a5443c854df1dd9fa7a035002577</gtr:id><gtr:otherNames>Zhang MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1863-2653</gtr:issn><gtr:outcomeId>56bdf0bb5d4db4.00811036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9A28308-FF98-4C5A-BD74-E416248AC0C5</gtr:id><gtr:title>Olfactory bulb involvement in neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc491cbf1f9eab8db94797a078078972"><gtr:id>bc491cbf1f9eab8db94797a078078972</gtr:id><gtr:otherNames>Attems J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_14481_21_24554308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0701D8CA-91A1-4B4C-AE1A-D7A1DCB5624C</gtr:id><gtr:title>Tau proteins in the temporal and frontal cortices in patients with vascular dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/659ed1570e6076fa5e9243e22763574d"><gtr:id>659ed1570e6076fa5e9243e22763574d</gtr:id><gtr:otherNames>Mukaetova-Ladinska EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>5675de6feb427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CC356C1-85FA-482C-A994-4E9C9B2F2068</gtr:id><gtr:title>Brain and other nervous system disorders across the lifespan - global challenges and opportunities.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d52dc32b79d0ffe8f7b43fd8d68edf7"><gtr:id>2d52dc32b79d0ffe8f7b43fd8d68edf7</gtr:id><gtr:otherNames>Silberberg D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56bdf0c04542b8.80018230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26C1A01C-46D2-46E0-8D7E-31F1861B8E53</gtr:id><gtr:title>Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373ede94ea3c44d7eca786be0b2c1d90"><gtr:id>373ede94ea3c44d7eca786be0b2c1d90</gtr:id><gtr:otherNames>Whitfield DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>56bdf0c176be55.23133503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>770BFECF-84B7-44C5-B145-0D69E37DDCA7</gtr:id><gtr:title>Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06746f665229e7a35d7006974998d4dc"><gtr:id>06746f665229e7a35d7006974998d4dc</gtr:id><gtr:otherNames>Lendvai D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_14481_21_22961619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>837EAAA3-27C4-4D93-A37B-90018AC5B496</gtr:id><gtr:title>An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ffb24d3ccf4afc20a2ffdb9e1f11a63"><gtr:id>7ffb24d3ccf4afc20a2ffdb9e1f11a63</gtr:id><gtr:otherNames>Lee C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>56bdf0bc4b0306.36945237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EBAB3FC-DF11-45C5-B9CD-50CB9E01B8F8</gtr:id><gtr:title>Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/035fd6446ad51dcfd45eac40f171f90d"><gtr:id>035fd6446ad51dcfd45eac40f171f90d</gtr:id><gtr:otherNames>Highley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0c38e3711.47958802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>496DC83A-6632-4FB0-ACBD-571FC11FDAAC</gtr:id><gtr:title>A reduced astrocyte response to ?-amyloid plaques in the ageing brain associates with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0932dcd014438629afa5aaa305271b53"><gtr:id>0932dcd014438629afa5aaa305271b53</gtr:id><gtr:otherNames>Mathur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56bdf0c463fc42.31720046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A0B197F-19E5-4573-8DEC-DE2AEF8EA6B8</gtr:id><gtr:title>The novel a7?2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e99a0dfb0dc5c8a03a5deed1f2cb0bae"><gtr:id>e99a0dfb0dc5c8a03a5deed1f2cb0bae</gtr:id><gtr:otherNames>Moretti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>doi_55faa1aa17da0c5f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BD84A7D-DD13-49ED-80D7-B8D3A4CE9BD4</gtr:id><gtr:title>DNA damage response and senescence in endothelial cells of human cerebral cortex and relation to Alzheimer's neuropathology progression: a population-based study in the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c58c64d02a3edc3d0ae27f66455b7e2"><gtr:id>6c58c64d02a3edc3d0ae27f66455b7e2</gtr:id><gtr:otherNames>Garwood CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0c5d9d7e7.18243350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C2245FA-87C1-435E-8E7E-328005CAD17B</gtr:id><gtr:title>The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells.</gtr:title><gtr:parentPublicationTitle>Journal of diabetes research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b72e1d6881b9ba971c51fb8db79b6a6"><gtr:id>2b72e1d6881b9ba971c51fb8db79b6a6</gtr:id><gtr:otherNames>Maj M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56bdf0bb9a73e7.40173080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A83D53F-A99C-43DA-AE5A-4B9DF0FEB12B</gtr:id><gtr:title>Mitochondrial DNA deletions and depletion within paraspinal muscles.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b7092e8b6da59c8d5f3b11ed7d2a72"><gtr:id>72b7092e8b6da59c8d5f3b11ed7d2a72</gtr:id><gtr:otherNames>Campbell GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481_12_01290_x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC2BBFA2-3618-46F2-9B63-DB918F97E7B6</gtr:id><gtr:title>Cellular morphometry in late-life depression: a review of postmortem studies.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b35b6025150bf880dd1dec8ed9955c8"><gtr:id>8b35b6025150bf880dd1dec8ed9955c8</gtr:id><gtr:otherNames>Khundakar AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>doi_14481_013_06_003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C23D040-987B-4D3D-B9EF-F55D9644D7B4</gtr:id><gtr:title>Quantitative neuropathological assessment to investigate cerebral multi-morbidity.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc491cbf1f9eab8db94797a078078972"><gtr:id>bc491cbf1f9eab8db94797a078078972</gtr:id><gtr:otherNames>Attems J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56bdf0bdd2a496.24410713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B191B580-A7BC-4B1B-8D4A-15ED782C298E</gtr:id><gtr:title>Neuropathological correlates of cerebral multimorbidity.</gtr:title><gtr:parentPublicationTitle>Current Alzheimer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc491cbf1f9eab8db94797a078078972"><gtr:id>bc491cbf1f9eab8db94797a078078972</gtr:id><gtr:otherNames>Attems J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-2050</gtr:issn><gtr:outcomeId>pm_14481_21_23627751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A800DD-5153-4836-9E2C-E7E2F1BDB9A8</gtr:id><gtr:title>Somatic mtDNA variation is an important component of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72ff3ff830765b467e00bb85c41d92c6"><gtr:id>72ff3ff830765b467e00bb85c41d92c6</gtr:id><gtr:otherNames>Coxhead J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56bdf0c2270a87.14681113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF48AE6E-41EB-4C8F-8D7C-186E7ABF2A8F</gtr:id><gtr:title>Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b35b6025150bf880dd1dec8ed9955c8"><gtr:id>8b35b6025150bf880dd1dec8ed9955c8</gtr:id><gtr:otherNames>Khundakar AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>56bdf0c10e9632.57161219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>610B67E7-ABBD-4968-9B8B-29EF925620DD</gtr:id><gtr:title>Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/255f14bfe5038a10c88615ffcedb9000"><gtr:id>255f14bfe5038a10c88615ffcedb9000</gtr:id><gtr:otherNames>Gr?newald A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56bdf0b9c60284.12810283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61C2C858-A48C-4FA7-8FC1-5B7C6E78F8F5</gtr:id><gtr:title>A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0c4babc46.06570842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3C61291-29B2-48C7-A152-0FC67246E7D1</gtr:id><gtr:title>Olfaction and Aging: A Mini-Review.</gtr:title><gtr:parentPublicationTitle>Gerontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc491cbf1f9eab8db94797a078078972"><gtr:id>bc491cbf1f9eab8db94797a078078972</gtr:id><gtr:otherNames>Attems J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-324X</gtr:issn><gtr:outcomeId>56bdf0bd2021b3.00026316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE736949-CE7E-4237-8755-FC58E3568BEB</gtr:id><gtr:title>Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.</gtr:title><gtr:parentPublicationTitle>Current Alzheimer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09876e6593394de33dd2c96b5b93034d"><gtr:id>09876e6593394de33dd2c96b5b93034d</gtr:id><gtr:otherNames>Akinyemi RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-2050</gtr:issn><gtr:outcomeId>pm_14481_21_23627757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE7D1CD1-CF05-4B89-AFEF-1D02FF23FD32</gtr:id><gtr:title>Clinicians' ability to diagnose dementia with Lewy bodies is not affected by ?-amyloid load.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba1069cee86627a6a18c7dbd8099ef7f"><gtr:id>ba1069cee86627a6a18c7dbd8099ef7f</gtr:id><gtr:otherNames>Tiraboschi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56bdf0bd9fa6d1.65043156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A01E2C8-E788-44D5-90A7-3D61F5BA258B</gtr:id><gtr:title>Unfolded protein response is activated in Lewy body dementias.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a7a5c519de42b38187e2dc3bf1f9516"><gtr:id>2a7a5c519de42b38187e2dc3bf1f9516</gtr:id><gtr:otherNames>Baek JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0bcdc7347.64930386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74A5C45E-43B6-479D-B2A4-234F3B18A421</gtr:id><gtr:title>Pathology of clinical and preclinical Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European archives of psychiatry and clinical neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8560799503306007f4fa1d8d856f8ad8"><gtr:id>8560799503306007f4fa1d8d856f8ad8</gtr:id><gtr:otherNames>Thal DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0940-1334</gtr:issn><gtr:outcomeId>doi_14481_013_0449_5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49D9993B-A9D3-47A1-A16F-0B2A5A7C8926</gtr:id><gtr:title>Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.</gtr:title><gtr:parentPublicationTitle>American journal of neurodegenerative disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce6eeacfdcd5222747dab3fa256a93b"><gtr:id>1ce6eeacfdcd5222747dab3fa256a93b</gtr:id><gtr:otherNames>Love S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2165-591X</gtr:issn><gtr:outcomeId>56bdf0c6166ce1.85012864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8264C071-0415-4BA4-8629-5C0E2F5108A4</gtr:id><gtr:title>Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b713041ea74e48ad43be6b3c33a3888"><gtr:id>7b713041ea74e48ad43be6b3c33a3888</gtr:id><gtr:otherNames>Bury JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>56bdf0c326eaf1.59106936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFA53B45-A58C-4B92-8B01-922941747CAA</gtr:id><gtr:title>Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8be76b4be2b2f7cd39c6b62a634ab40b"><gtr:id>8be76b4be2b2f7cd39c6b62a634ab40b</gtr:id><gtr:otherNames>Beer AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>56bdf0c50f2f92.24629253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>437B0794-6739-4B3E-9E0B-A24189C78C02</gtr:id><gtr:title>High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa3b0a88bb8afb442368a3692f60fc82"><gtr:id>fa3b0a88bb8afb442368a3692f60fc82</gtr:id><gtr:otherNames>Fuchs EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>pm_14481_21_24311197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B031B6A-FB22-4572-BF16-AEB92382C5B2</gtr:id><gtr:title>Neural differentiation modulates the vertebrate brain specific splicing program.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/750840484d74888bfee9cfb139127dea"><gtr:id>750840484d74888bfee9cfb139127dea</gtr:id><gtr:otherNames>Madgwick A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56bdf0ba2b7af0.96035036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8932468-1FD9-49AA-ACD5-2D400498B277</gtr:id><gtr:title>Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0acd0a2afad7dd3cf59d66f33d1c1f4"><gtr:id>b0acd0a2afad7dd3cf59d66f33d1c1f4</gtr:id><gtr:otherNames>Yamamoto Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>doi_14481_31829020b5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C138228-C22B-4079-9BEA-CD5230CC6CD6</gtr:id><gtr:title>Neuropathological approaches to cerebral aging and neuroplasticity.</gtr:title><gtr:parentPublicationTitle>Dialogues in clinical neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1fb52256797bd3233e9e4e957139890"><gtr:id>b1fb52256797bd3233e9e4e957139890</gtr:id><gtr:otherNames>Jellinger KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1294-8322</gtr:issn><gtr:outcomeId>pm_14481_21_23576887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12AF1123-CA12-4AAE-9996-0FA6DE43F9A3</gtr:id><gtr:title>Investigating complex I deficiency in Purkinje cells and synapses in patients with mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ac9010b8fd67e4b517628ed4d73c5ab"><gtr:id>7ac9010b8fd67e4b517628ed4d73c5ab</gtr:id><gtr:otherNames>Chrysostomou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0be2ef8c2.60890961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EC871A0-3C6B-4090-BA0A-29EFBE6924C0</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56bdf0bad05b50.20318177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71DB0538-C06D-4464-BD3E-DB7E7B656AEF</gtr:id><gtr:title>Using Human iPSC-Derived Neurons to Model TAU Aggregation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5259073f2d5f081e26ca04ebf2547c9a"><gtr:id>5259073f2d5f081e26ca04ebf2547c9a</gtr:id><gtr:otherNames>Verheyen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56bdf0c70db088.41740875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A30AF46-8B2A-4F86-B1B8-66F4491110A2</gtr:id><gtr:title>Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef42ad98d03874e0f8eb5e0fb99cff5"><gtr:id>3ef42ad98d03874e0f8eb5e0fb99cff5</gtr:id><gtr:otherNames>Craggs L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0c072c666.92708733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>255FEEAF-FA27-47F2-9CD3-84AC9FE57810</gtr:id><gtr:title>Genome-wide association study of neocortical Lewy-related pathology.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7c17ed5c2cf001307b1ed15341ae8d2"><gtr:id>b7c17ed5c2cf001307b1ed15341ae8d2</gtr:id><gtr:otherNames>Peuralinna T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>56bdf0c2ea47e0.07895134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>767079CE-FEBF-457F-8A74-55CFEF2C493F</gtr:id><gtr:title>Dementia: Vascular and neurodegenerative pathways-will they meet?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b04d476e7d78b30dd4256fc59a974191"><gtr:id>b04d476e7d78b30dd4256fc59a974191</gtr:id><gtr:otherNames>Kalaria RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>doi_14481_l_2013_164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDA65B08-0A15-43D5-8D91-BAF21A3263D7</gtr:id><gtr:title>Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11e591749d9e03d48c9eff836f040718"><gtr:id>11e591749d9e03d48c9eff836f040718</gtr:id><gtr:otherNames>Chen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bdf0c013c1c1.95763513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8FE0C3E-3680-4FE4-B93C-4524FB0DEC31</gtr:id><gtr:title>Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3cccc204cd9d3d87ee07e51f0dbaf3a"><gtr:id>b3cccc204cd9d3d87ee07e51f0dbaf3a</gtr:id><gtr:otherNames>Pienaar IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>56bdf0c09c4b82.58267046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EBBD0E2-D227-411B-A353-40BEC38F8505</gtr:id><gtr:title>Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9f8b824f1f03417d13c49f0abbe2c97"><gtr:id>e9f8b824f1f03417d13c49f0abbe2c97</gtr:id><gtr:otherNames>Craggs LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>doi_14481__bpa_12041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3DE6BDE-9552-4243-9CEE-2B20ACB222BE</gtr:id><gtr:title>Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7ab308611896920e4aca79171d9514"><gtr:id>3c7ab308611896920e4aca79171d9514</gtr:id><gtr:otherNames>Janaway BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481__nan_12062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FEB23D6-4818-4CFE-B7EA-2CE4CB56404C</gtr:id><gtr:title>Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5bb0f592e8014472d5082208157baad"><gtr:id>c5bb0f592e8014472d5082208157baad</gtr:id><gtr:otherNames>Cooper-Knock J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56bdf0c3f41a63.26712904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>265BAC7B-4E80-45EE-BFF9-AD643EA4CD3D</gtr:id><gtr:title>Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d701cd80451e6067dc025280135c8c99"><gtr:id>d701cd80451e6067dc025280135c8c99</gtr:id><gtr:otherNames>Vallortigara J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>56bdf0bc1b3567.15776418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1899645B-10DC-44C7-B750-99E0487DE6AF</gtr:id><gtr:title>Deposition of amyloid ? in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6064a4d07cab171f38b6cdd1227ad29"><gtr:id>e6064a4d07cab171f38b6cdd1227ad29</gtr:id><gtr:otherNames>Keable A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56bdf0bcaa7584.02989687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A9BCA9E-81F2-4062-9BDE-EAD5790F0E73</gtr:id><gtr:title>Amyloid and tau: neither chicken nor egg but two partners in crime!</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc491cbf1f9eab8db94797a078078972"><gtr:id>bc491cbf1f9eab8db94797a078078972</gtr:id><gtr:otherNames>Attems J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_14481_21_23955601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B25B521D-8731-4423-B10E-A7601E2672DF</gtr:id><gtr:title>Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56bdf0b9f15db5.99885713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAE48854-F48D-4B5E-AEDC-6016D024BDB5</gtr:id><gtr:title>Cortical tau load is associated with white matter hyperintensities.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/901b3db03fc36caf8f8bfdd82761bc5a"><gtr:id>901b3db03fc36caf8f8bfdd82761bc5a</gtr:id><gtr:otherNames>McAleese KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56c1abdb83bdb9.68652154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72C25BB3-D8BE-4431-828C-5EB294086BD6</gtr:id><gtr:title>Pyroglutamylated amyloid-? is associated with hyperphosphorylated tau and severity of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bddc68b4542db82291004c32b65bc53"><gtr:id>3bddc68b4542db82291004c32b65bc53</gtr:id><gtr:otherNames>Mandler M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>545b40af4e0336.72426608</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2DB8C35-E10D-4719-95AE-319ED1DF6597</gtr:id><gtr:title>Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/901b3db03fc36caf8f8bfdd82761bc5a"><gtr:id>901b3db03fc36caf8f8bfdd82761bc5a</gtr:id><gtr:otherNames>McAleese KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481_12_01310_x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DEDC0B9-6332-4744-B256-A7358FBC8B56</gtr:id><gtr:title>Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0c3b961c7.28617859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13B35358-F4D7-435A-91F3-D100515E32F3</gtr:id><gtr:title>White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9f8b824f1f03417d13c49f0abbe2c97"><gtr:id>e9f8b824f1f03417d13c49f0abbe2c97</gtr:id><gtr:otherNames>Craggs LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481__nan_12073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F8BF9A4-90A9-4477-9663-6817F750A39C</gtr:id><gtr:title>Spreading pathologies precede cognitive decline in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1da287f55a621cd5e9876bc34531117"><gtr:id>e1da287f55a621cd5e9876bc34531117</gtr:id><gtr:otherNames>Howlett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>56bdf0bd476367.13789559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05BD07ED-96C4-43EB-AEC0-904A12579E02</gtr:id><gtr:title>Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f57af54aaf68af39c7fb8a5b1854743"><gtr:id>1f57af54aaf68af39c7fb8a5b1854743</gtr:id><gtr:otherNames>Garwood C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>doi_14481__nan_12033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>601E9061-3A10-49D9-B9D8-B1A4F1AEA259</gtr:id><gtr:title>Altered expression of ZnT10 in Alzheimer's disease brain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cff53e7158e959835f12e280067ca5f"><gtr:id>4cff53e7158e959835f12e280067ca5f</gtr:id><gtr:otherNames>Bosomworth HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_14481_ne_0065475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1D1AFA5-F2B1-42BB-B8CF-CD2965B63D17</gtr:id><gtr:title>Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498bed82ae06288d048197db7cccb49b"><gtr:id>498bed82ae06288d048197db7cccb49b</gtr:id><gtr:otherNames>Al-Mashhadi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56bdf0c53d1531.72919960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>651AF334-794B-47CB-A863-5E5A965A61B3</gtr:id><gtr:title>Stroke injury, cognitive impairment and vascular dementia.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b04d476e7d78b30dd4256fc59a974191"><gtr:id>b04d476e7d78b30dd4256fc59a974191</gtr:id><gtr:otherNames>Kalaria RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56bdf0bfd63a49.94349532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2FF059A-DC8A-4987-85D5-399277DBD7EA</gtr:id><gtr:title>Diagnostic criteria for vascular cognitive disorders: a VASCOG statement.</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bb5f2794534ece4314ba38bafd6dd35"><gtr:id>8bb5f2794534ece4314ba38bafd6dd35</gtr:id><gtr:otherNames>Sachdev P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>56bdf0c0cc5211.44646148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>490460B1-FE54-4DA1-97B6-4D33F3D1658F</gtr:id><gtr:title>Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b84e3efddf91ce32c4275d8e133ebf2a"><gtr:id>b84e3efddf91ce32c4275d8e133ebf2a</gtr:id><gtr:otherNames>Walker L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56c1ad83828b34.78871468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A70036F7-9BE9-41AC-80B6-8D726432DBD8</gtr:id><gtr:title>Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ed471b987fd0e51e8e350a5e0f02553"><gtr:id>6ed471b987fd0e51e8e350a5e0f02553</gtr:id><gtr:otherNames>Mohamed NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>doi_14481_013_1067_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59A23A3B-EB60-45A0-8B11-AC71D7E8017D</gtr:id><gtr:title>Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56bdf0bbd55ac7.46797412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF7689E0-42B8-47A8-A06B-031C170E791E</gtr:id><gtr:title>Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56bdf0c2b02876.11936791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71ADD34E-438F-4CBF-B630-570E6EE52EBC</gtr:id><gtr:title>Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/035fd6446ad51dcfd45eac40f171f90d"><gtr:id>035fd6446ad51dcfd45eac40f171f90d</gtr:id><gtr:otherNames>Highley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0c64262a9.85963774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0104D553-44A5-4714-BD84-02FF1107FFC9</gtr:id><gtr:title>Intralobar fibres of the occipital lobe: a post mortem dissection study.</gtr:title><gtr:parentPublicationTitle>Cortex; a journal devoted to the study of the nervous system and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba9039867455ffc48b92db279df2d289"><gtr:id>ba9039867455ffc48b92db279df2d289</gtr:id><gtr:otherNames>Vergani F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0010-9452</gtr:issn><gtr:outcomeId>56bdf0bb2dd830.11916990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF6A221-147B-4FD4-BBB2-6DBCE4EE2F33</gtr:id><gtr:title>White matter changes in dementia: role of impaired drainage of interstitial fluid.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/826529c33c68789b9df7c19ab1cfcc21"><gtr:id>826529c33c68789b9df7c19ab1cfcc21</gtr:id><gtr:otherNames>Weller RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>doi_55faa1aa17c7b942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>403D5C53-8EDE-44FE-8E13-3DD5800FC6C2</gtr:id><gtr:title>Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf606bbf34d58349a60e04154d1442fd"><gtr:id>cf606bbf34d58349a60e04154d1442fd</gtr:id><gtr:otherNames>Erskine D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56bdf0ba606f17.50004624</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L016451/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>